ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why INT012367 is on this study

  • The record lists it as a treatment, written “VET3-TGI”.
  • Claude Opus 5.5 judged it tested: part of what the study tests. Nov 3, 2026, 5:03 AM UTC
  • The role rule says the same.
  • So INT012367's page lists this study under “Testing it”.
10 links0 made here, not in the record13 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT06444815A Study of VET3-TGI inPatients With Solid TumorsKaliVir ImmunotherapeuticsPhase 1 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 17 · ClinicalTrials.gov record · Version of 2026-11-17Version of 2026-11-17CONDITIONSSquamous Cell Carcinoma of …The registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionUterine Cervical NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termKidney NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedCarcinoma, Renal CellThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termMelanomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termMesotheliomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCarcinoma, Squamous CellThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSINT012367Entry “VET3-TGI”, read by our name ru…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAtezolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
1 version of the record seen on ClinicalTrials.gov, Nov 17 · changes seen, not judgments
Nov 3INT012367Claude Opus 5.5TestedCurrent
Nov 3AtezolizumabClaude Opus 5.5Background · partnerCurrent
Nov 14Squamous Cell Carcinoma of Head and NeckRule based · condition-kind ruleFinest filed termCurrent
Nov 14Uterine Cervical NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Kidney NeoplasmsRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Carcinoma, Renal CellRule based · condition-kind ruleFinest filed termCurrent
Nov 14MelanomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14MesotheliomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, Squamous CellRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18INT012367Rule based · role ruleTestedAgrees
Nov 18AtezolizumabRule based · role ruleBackgroundAgrees
As of nowSquamous Cell Carcinoma of Head and NeckRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.